| Nome do produto |
Prostaglandin E2 |
| Nome em inglês |
Prostaglandin E2; (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate; 7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid; PGE2; Prosta-5,13-diene-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11a,13E15S)-; Dinoprostone; Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,8ξ,12ξ,13E)-; (11alpha,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5E,13E)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid; (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oate |
| Fórmula molecular |
C20H31O5 |
| Peso Molecular |
351.4577 |
| InChI |
InChI=1/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/p-1/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1 |
| CAS Registry Number |
363-24-6;154170-57-7 |
| EINECS |
206-656-6 |
| Estrutura Molecular |
|
| Ponto de fusão |
66-68℃ |
| Ponto de ebulição |
530.071°C at 760 mmHg |
| O ponto de inflamação |
288.452°C |
| solubilidade em água |
insoluble |
| Pressão de vapor |
0mmHg at 25°C |
| SÃmbolos de perigo |
 T:Toxic;
|
| Códigos de risco |
R60:;
R22:;
|
| Descrição da Segurança |
S53:;
S22:;
S26:;
S36/37/39:;
|
|
